A Breakthrough in Rehabilitation for Spinal Cord Injury Patients

On December 19, 2024, Onward Medical received groundbreaking FDA approval for its ARC-EX non-invasive spinal cord stimulator, offering new hope for individuals with spinal cord injuries. This innovative device aims to revolutionize the rehabilitation process by enhancing hand sensation and strength. In clinical trials, 72% of participants experienced significant improvements, underscoring the potential of this device as a key tool in recovery.

Spinal cord injuries often lead to severe mobility limitations and loss of independence. While the ARC-EX cannot replace traditional rehabilitative therapies, its impact has been profound. Participants in the trials, like Sherown Campbell, who sustained a neck injury while wrestling in 2014, reported impressive gains. “I didn’t think I would be able

to move as much as I do, or as close to normal as I am,” Campbell shared, highlighting the transformative effects of the ARC-EX.

This FDA approval opens the door to a whole new paradigm in spinal cord injury treatment, providing patients with a promising non-invasive option to aid in their recovery and enhance their quality of life. As the demand for less invasive treatments grows, devices like ARC-EX are paving the way for advancements in spinal cord injury rehabilitation.